Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 13/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 13/20 | 0.45 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.33 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1032150 | 0.91 | CYP1A1 (0.47) | CYP1A1CYP1B1MAOBDPP4ESR1 | |
| SCHEMBL28814915 | 0.90 | CYP1A1 (0.37) | CYP1A1CYP1B1MAOBDPP4CXCL12 | |
| SCHEMBL1031699 | 0.89 | CYP1A1 (0.46) | CYP1A1CYP1B1MAOBDPP4ESR1 | |
| SCHEMBL1034157 | 0.89 | CYP1A1 (0.45) | CYP1A1CYP1B1MAOBDPP4ESR1 | |
| SCHEMBL1033785 | 0.87 | CYP1A1 (0.47) | CYP1A1CYP1B1MAOBDPP4ESR1 | |
| SCHEMBL1031670 | 0.87 | CYP1A1 (0.50) | CYP1A1CYP1B1MAOBDPP4ESR1 | |
| SCHEMBL27988466 | 0.80 | CYP1A1 (0.40) | CYP1A1CYP1B1MAOBDPP4TNFRSF1A | |
| SCHEMBL28814942 | 0.79 | CYP1A1 (0.38) | CYP1A1CYP1B1MAOBDPP4 | |
| SCHEMBL27988132 | 0.78 | CYP1A1 (0.40) | CYP1A1CYP1B1MAOBDPP4TNFRSF1A | |
| SCHEMBL27988140 | 0.78 | CYP1A1 (0.38) | CYP1A1CYP1B1MAOBDPP4CXCL12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3424917-A1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | Nippon Chemiphar Co., Ltd. (JP) | 2019-01-09 | — | — | EP | disclosed |
| EP-2277874-B1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | NIPPON CHEMIPHAR CO (JP) | 2018-06-27 | — | — | EP | disclosed |
| US-8648208-B2 | Activating agent for peroxisome proliferator activated receptor | NIPPON CHEMIPHAR CO. LTD. (JP) | 2014-02-11 | — | — | US | disclosed |
| US-20110098480-A1 | ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | NIPPON CHEMIPHAR CO. LTD. (JP) | 2011-04-28 | — | — | US | disclosed |
| EP-2277874-A1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | Nippon Chemiphar Co., Ltd. (JP) | 2011-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098480-A1 | ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | PPARA, PPARG, PPARD | CYP1A1 354/4885CYP1B1 413/4885MAOB 3286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.